CELERIS CORP
10-Q, EX-27.1, 2000-11-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CELERIS CORP, 10-Q, EX-10.1, 2000-11-13
Next: CELERIS CORP, 10-Q, EX-99.1, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF CELERIS CORPORATION DATED SEPTEMBER 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       6,117,820
<SECURITIES>                                         0
<RECEIVABLES>                                2,360,332
<ALLOWANCES>                                   316,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                             8,807,620
<PP&E>                                       1,453,659
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              10,261,279
<CURRENT-LIABILITIES>                        2,781,224
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        31,787
<OTHER-SE>                                   7,293,167
<TOTAL-LIABILITY-AND-EQUITY>                10,261,279
<SALES>                                      8,025,375
<TOTAL-REVENUES>                             8,025,375
<CGS>                                        5,655,243
<TOTAL-COSTS>                                5,434,662
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (2,797,343)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (2,797,343)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (2,797,343)
<EPS-BASIC>                                      (0.89)
<EPS-DILUTED>                                    (0.89)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission